EGMN -- Last year’s pandemic H1N1 infection was especially dangerous for solid organ transplant recipients, although individuals who received early antiviral therapy experienced less morbidity and better outcomes compared with those who did not, according to a study reported online July 9 in the Lancet Infectious Diseases.
